
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions โ written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Cholesterol emboli syndrome pathophysiology
Introduction
Overview
Overview
Cholesterol emboli syndrome (CES) is the result of the rupture and release of cholesterol crystals from atherosclerotic plaques, produced either spontaneously or iatrogenic that lead to mechanical obstruction of arterioles and inflammatory response activation that cause multiple organ damage.
Pathophysiology
Pathophysiology
- It is thought that cholesterol emboli syndrome (CES) is the result of the rupture and release of cholesterol crystals from atherosclerotic plaques, produced either spontaneously or as a result of iatrogenesis.[1][2]
- Cholesterol emboli syndrome (CES) is defined as the occlusion of 100-200 ยตm arterioles by cholesterol crystals after their dislodgment from atheromatous plaques, which arise from proximal large arteries such as aorta.[1]
- Embolization of cholesterol crystals lead to several damages including[1]
- Endothelial injury
- Activation of complement system
- Oxidative stress injury
- Activation of the reninโangiotensinโaldosterone system (RAAS) due to renal arteries obstruction and hypoperfusion
- Leukocyte infiltration and release of its enzymes which cause inflammation
- Cholesterol emboli can involve many organs including brain, kidneys, eyes, skin, muscles, and gastrointestinal tract. [3]
References
References
- โ 1.0 1.1 1.2 Ozkok, Abdullah (2016). “Cholesterol embolization syndrome: report of two cases”. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. doi:10.5543/tkda.2015.94587. ISSNย 1016-5169.
- โ Ozkok, Abdullah (2019). “
Cholesterol-embolization syndrome: current perspectives
“. Vascular Health and Risk Management. Volume 15: 209โ220. doi:10.2147/VHRM.S175150. ISSNย 1178-2048. - โ Shah N, Nagalli S. PMIDย 32310551 Check
|pmid=value (help). Missing or empty|title=(help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
